Press Releases

Novodiax was voted the “Best Immunoassays Development Company for 2018 & the Most Innovative IHC Technology company” for the Company’s innovative ihcDirect Products. The award was given at the Third-Annual Biotechnology Awards by GHP (Global Health & Pharma). Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays. Novodiax’s proprietary supersensitive enzymatic signal amplification detection system provides a revolutionary 10 minute Intraoperative IHC result and accelerates Companion diagnostic development.